P
Prostemics Co Ltd
KOSDAQ:203690
Prostemics Co Ltd
KOSDAQ:203690
Price:
4 425
KRW
-1.67%
Market Cap:
₩58.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Popular Picks
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Prostemics Co Ltd
Total Current Liabilities
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Prostemics Co Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Prostemics Co Ltd
KOSDAQ:203690
|
Total Current Liabilities
₩12.6B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
25%
|
CAGR 10-Years
19%
|
|
|
Celltrion Inc
KRX:068270
|
Total Current Liabilities
₩4.5T
|
CAGR 3-Years
51%
|
CAGR 5-Years
33%
|
CAGR 10-Years
21%
|
|
|
SK Bioscience Co Ltd
KRX:302440
|
Total Current Liabilities
₩326.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
V
|
Voronoi Inc
KOSDAQ:310210
|
Total Current Liabilities
₩6.8B
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
N/A
|
|
|
Alteogen Inc
KOSDAQ:196170
|
Total Current Liabilities
₩239.7B
|
CAGR 3-Years
36%
|
CAGR 5-Years
62%
|
CAGR 10-Years
89%
|
|
|
A
|
ABL Bio Inc
KOSDAQ:298380
|
Total Current Liabilities
₩123.5B
|
CAGR 3-Years
20%
|
CAGR 5-Years
73%
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Prostemics Co Ltd
Glance View
PROSTEMICS Co., Ltd. engages in the provision of stem cell cosmetics and medicine. The company is headquartered in Seoul, Seoul. The company went IPO on 2014-09-30.
Intrinsic Value
3 405.25
KRW
Overvaluation 23%
P
See Also
What is Prostemics Co Ltd's Total Current Liabilities?
Total Current Liabilities
12.6B
KRW
12.6B
KRW
Based on the financial report for Sep 30, 2025, Prostemics Co Ltd's Total Current Liabilities amounts to 12.6B KRW.
What is Prostemics Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
19%
19%
Over the last year, the Total Current Liabilities growth was -61%. The average annual Total Current Liabilities growth rates for Prostemics Co Ltd have been -33% over the past three years , 25% over the past five years , and 19% over the past ten years .
